Medicare has started covering obesity drugs for the first time – and companies like Walmart and CVS

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combi

@Theotrade 's Don Kaufman takes us through today's Big 3 and offers example trades for his picks. He

This relationship between inflation and value stocks' outperformance is often overlooked. Many inves

CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take

Joel Greenblatt's Magic Formula, popularized in The Little Book That Beats the Market, ranks stocks

CVS Health announced a program to help patients get easier access to GLP-1 medicines. This initiativ

Local organizations receive Hometown Fund support to expand access to health care, food, housing and

Local organizations receive Hometown Fund support to expand access to health care, food, housing and

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

B of A Securities analyst Allen Lutz maintains CVS Health (NYSE:CVS) with a Buy and raises the pr

On June 22, 2026, CVS Health Corp (CVS) shares rose 3.0% to a current price of $101.30. The stock ha

Novo-Nordisk shares are trading higher by more than 6% on Monday as GLP‑1 support initiatives aimed

It is to start participating in a Medicare discount program for such medications, among other measur

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

As demand for GLP-1 medications continues to increase across the U.S., CVS Health® (NYSE:CVS) today

New $50 monthly copay for eligible Medicare patients, one-on-one pharmacist guidance, and over-the-c

Does CVS Health (CVS) have what it takes to be a top stock pick for momentum investors? Let's find o

Jim Cramer endorsed Vistra, expressed caution on Fair Isaac over AI risks: "I'm not going to

CVS Health's financial results are improving due to several initiatives. These efforts could continu

Earlier this month, Mizuho's Ann Hynes raised her price target to $115 per share. Following the late

STNE, USNA, STRA, NEXA and CVS passed a low price-to-book screen, combining discounted valuations wi

CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take

Federal investigators found Medicare Advantage plans frequently denied requests for nursing and reha

Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Outperform and raises the price t

Morgan Stanley names UnitedHealth its top managed care pick, citing AI-driven growth, efficiency gai

Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises t

The battle between Amazon.com and Walmart has produced a new leader for the Fortune 500 list for 202

Truist Securities analyst David Macdonald maintains CVS Health (NYSE:CVS) with a Buy and raises t

Eli Lilly (NYSE:LLY) shares jumped on Thursday morning after securing expanded PBM coverage for its

This expanded use of Agentforce Health, Salesforce's industry vertical solution for health care

These changes build on Caremark's industry leading efforts as a pharmacy benefits manager to exp

Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Outperform and raises the price t

Major M&A deals this week include: LVMH agrees to sell Marc Jacobs to WHP Global, 365 Markets bu

Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises t

Omnicare, LLC (the "Company" or "Omnicare"), a subsidiary of CVS Health (NYSE: CVS),

Bernstein analyst Lance Wilkes maintains CVS Health (NYSE:CVS) with a Outperform and raises the p

JP Morgan analyst Lisa Gill maintains CVS Health (NYSE:CVS) with a Overweight and raises the pric

https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-warns-cvs-potential-m

TD Cowen analyst Charles Rhyee maintains CVS Health (NYSE:CVS) with a Buy and raises the price ta

NVIDIA and CVS Health named as top final trades by industry experts, while Transocean and Vertiv Hol

Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Overweight and raises t

UBS analyst Kevin Caliendo maintains CVS Health (NYSE:CVS) with a Buy and raises the price target

CVS Health (NYSE:CVS) reported upbeat Q1 earnings & raised 2026 guidance. Analysts have positive

RBC Capital analyst Ben Hendrix maintains CVS Health (NYSE:CVS) with a Outperform and raises the

Barclays analyst Andrew Mok maintains CVS Health (NYSE:CVS) with a Overweight and raises the pric

Truist Securities analyst David Macdonald maintains CVS Health (NYSE:CVS) with a Buy and raises t

Evercore ISI Group analyst Elizabeth Anderson maintains CVS Health (NYSE:CVS) with a Outperform a